PI3K/AKT/GSK3β regulatory axis in bone mesenchymal stem cells initiates diabetic myocardial infarction <i>via</i> miR-142-3p
The preliminary results showed that the therapeutic mechanism of BMCs in diabetes myocardial infarction may involve miR-142-3p <i>via</i> the PI3K/AKT/GSK-3β axis, which jointly inhibits ferroptosis and programmed death.
Authors
- Liang Xu (ORCID: https://orcid.org/0000-0001-8946-8280)
- Yi Sun (ORCID: https://orcid.org/0000-0001-5051-8084)
- Ning Gao (ORCID: https://orcid.org/0000-0003-1605-4137)
- Qingqing Shen (ORCID: https://orcid.org/0000-0002-6251-8564)
- Tian Zheng (ORCID: https://orcid.org/0000-0003-4889-0391)
- Feifei Wang (ORCID: https://orcid.org/0000-0001-8502-966X)
- Xiaoling Liu (ORCID: https://orcid.org/0000-0002-8750-373X)
- Xuejing Li (ORCID: https://orcid.org/0000-0003-2475-6796)
- Yumeng Li (ORCID: https://orcid.org/0000-0002-9986-5201)
- Peng-Fei Wu
- Mingying Wu
- Liuxue Yang
Institutions
- Guilin Medical University (CN)
- Taiwan Centers for Disease Control (TW)
- Zaozhuang University (CN)
- Shandong Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- World Journal of Experimental Medicine
- Published
- 2025-08-12
- DOI
- https://doi.org/10.5493/wjem.v15.i3.103948
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00